We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MGDL:TASEMigdal Insurance & Financial Holdings Ltd. Analysis

Data as of 2026-03-14 - not real-time

ILA 1,795.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock is trading above its twenty‑day and fifty‑day simple moving averages, supporting a bullish market direction, while the relative strength index hovers around the neutral midpoint. Momentum indicators show a mixed picture: the MACD histogram is negative, hinting at underlying bearish pressure, and the price sits comfortably above the identified support level but below the key resistance zone. Volatility is notably high, yet the beta remains very low, indicating limited sensitivity to broader market swings.
Fundamentally, the company delivers solid revenue growth and a strong operating margin, backed by a massive cash reserve that dwarfs its modest debt load. However, free cash flow is negative and the price‑to‑book multiple is extraordinarily elevated, creating a tension between the DCF‑derived intrinsic value—far above the current price—and traditional valuation multiples. The dividend is modest with an extremely low payout ratio, suggesting sustainability, but the overall valuation picture leans toward being undervalued relative to intrinsic estimates, albeit with caution due to the high book multiple.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price above short‑term moving averages
  • bearish MACD histogram
  • proximity to resistance level

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • large gap between DCF fair value and market price
  • low beta and strong cash position
  • moderate revenue growth and solid operating margins

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • sustainable dividend with low payout ratio
  • potential for long‑term appreciation given intrinsic undervaluation
  • stable insurance business in a low‑risk geographic market

Key Metrics & Analysis

Financial Health

Revenue Growth11.90%
Profit Margin2.13%
P/E Ratio26.4
ROE7.83%
ROA0.40%
Debt/Equity81.85
P/B Ratio197.8
Op. Cash FlowILA7.6B
Free Cash FlowILA-80536576000
Industry P/E16.4

Technical Analysis

TrendBullish
RSI50.0
SupportILA 1,627.00
ResistanceILA 1,948.00
MA 20ILA 1,827.10
MA 50ILA 1,738.94
MA 200ILA 1,213.32
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueILA 24,674.64
GradeUndervalued
TypeBlend
Dividend Yield0.49%

Risk Assessment

Beta0.16
Volatility51.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.